VGF及其衍生在肌缩侧面硬化症中的作用
Antonio Luigi Manai1, Paola Caria2, Barbara Noli1
1NEF-Laboratory, Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy.
Brain sciences
|May 1, 2025
概括
肌缩侧面硬化症 (ALS) 诊断是具有挑战性的,因为缺乏早期生物标志物. 对体液中的proVGF的研究为早期检测和新的治疗策略提供了潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 生物标志物发现发现
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,没有有效的治疗方法.
- 由于缺乏早期生物标志物而导致的诊断延迟,阻碍了治疗策略的制定.
- 目前的神经递质生物标志物在身体液体中无法可靠地检测到ALS诊断.
研究的目的:
- 探索proVGF衍生的潜力,作为ALS的早期诊断生物标志物.
- 审查ALS患者脊髓和体液中VGF的变化.
- 确定当前研究的局限性,并指导未来的调查.
主要方法:
- 文献综述侧重于proVGF和它们在ALS中的作用.
- 分析使用质谱和生物化学测试检测神经的研究.
- 在神经组织和体液中检查VGF的表达.
主要成果:
- ProVGF在神经和内分泌系统中表达,在血液,尿液和脑脊液中发现.
- 在ALS中,在脊髓和体液中观察到VGF水平的改变.
- 这些可以作为ALS诊断的潜在生物标志物.
结论:
- 来自ProVGF的体代表了开发ALS早期诊断生物标志物的有希望的途径.
- 需要进一步的研究来克服当前研究的局限性,并验证这些.
- 识别可靠的生物标志物对于推进针对ALS的治疗策略至关重要.
相关概念视频
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
Myasthenia Gravis: Overview and Treatment
996
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
996


